BCRX
Biocryst Pharmaceuticals IncCompany with tickers: BCRX
CIK
882796
CUSIP
09058V103
Shares Outstanding
254,162,660
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $60,319,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $-701,598,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-721,812,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-2.98 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $-2.98 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |